Skip to main content
Erschienen in: Digestive Diseases and Sciences 3/2012

01.03.2012 | Original Article

Xenon-Inhalation Computed Tomography for Noninvasive Quantitative Measurement of Tissue Blood Flow in Pancreatic Tumor

verfasst von: Masaru Kubota, Takamichi Murakami, Hiroaki Nagano, Hidetoshi Eguchi, Shigeru Marubashi, Shogo Kobayashi, Hiroshi Wada, Masahiro Tanemura, Keizo Dono, Shoji Nakamori, Masato Sakon, Morito Monden, Masaki Mori, Yuichiro Doki

Erschienen in: Digestive Diseases and Sciences | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Background and Aims

The purpose of this prospective study was to demonstrate the ability to measure pancreatic tumor tissue blood flow (TBF) with a noninvasive method using xenon inhalation computed tomography (xenon-CT) and to correlate TBF with histological features, particularly microvascular density (MVD).

Methods

TBFs of pancreatic tumors in 14 consecutive patients were measured by means of xenon-CT at diagnosis and following therapy. Serial abdominal CT scans were obtained before and after inhalation of nonradioactive xenon gas. TBF was calculated using the Fick principle. Furthermore, intratumoral microvessels were stained with anti-CD34 monoclonal antibodies before being quantified by light microscopy (×200). We evaluated MVD based on CD34 expression and correlated it with TBF.

Results

The quantitative TBF of pancreatic tumors measured by xenon CT ranged from 22.3 to 111.4 ml/min/100 g (mean ± SD, 59.6 ± 43.9 ml/min/100 g). High correlation (r = 0.885, P < 0.001) was observed between TBF and intratumoral MVD.

Conclusion

Xenon-CT is feasible in patients with pancreatic tumors and is able to accurately estimate MVD noninvasively.
Literatur
1.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRef Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRef
2.
Zurück zum Zitat Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.PubMedCrossRef Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.PubMedCrossRef
3.
Zurück zum Zitat Egawa S, Takeda K, Fukuyama S, Motoi F, Sunamura M, Matsuno S. Clinicopathological aspects of small pancreatic cancer. Pancreas. 2004;28:235–240.PubMedCrossRef Egawa S, Takeda K, Fukuyama S, Motoi F, Sunamura M, Matsuno S. Clinicopathological aspects of small pancreatic cancer. Pancreas. 2004;28:235–240.PubMedCrossRef
4.
Zurück zum Zitat Rothenberg ML, Moore MJ, Cripps MC, et al. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol. 1996;7:347–353.PubMed Rothenberg ML, Moore MJ, Cripps MC, et al. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol. 1996;7:347–353.PubMed
5.
Zurück zum Zitat Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15:2403–2413.PubMed Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15:2403–2413.PubMed
6.
Zurück zum Zitat Reuter SR, Redman HC, Bookstein JJ. Differential problems in the angiographic diagnosis of carcinoma of the pancreas. Radiology. 1970;96:93–99.PubMed Reuter SR, Redman HC, Bookstein JJ. Differential problems in the angiographic diagnosis of carcinoma of the pancreas. Radiology. 1970;96:93–99.PubMed
7.
Zurück zum Zitat Miles KA, Hayball MP, Dixon AK. Measurement of human pancreatic perfusion using dynamic computed tomography with perfusion imaging. Br J Radiol. 1995;68:471–475.PubMedCrossRef Miles KA, Hayball MP, Dixon AK. Measurement of human pancreatic perfusion using dynamic computed tomography with perfusion imaging. Br J Radiol. 1995;68:471–475.PubMedCrossRef
8.
Zurück zum Zitat Abe H, Murakami T, Kubota M, et al. Quantitative tissue blood flow evaluation of pancreatic tumor: comparison between xenon CT technique and perfusion CT technique based on deconvolution analysis. Radiat Med. 2005;23:364–370.PubMed Abe H, Murakami T, Kubota M, et al. Quantitative tissue blood flow evaluation of pancreatic tumor: comparison between xenon CT technique and perfusion CT technique based on deconvolution analysis. Radiat Med. 2005;23:364–370.PubMed
9.
Zurück zum Zitat Sofuni A, Iijima H, Moriyasu F, et al. Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. J Gastroenterol. 2005;40:518–525.PubMedCrossRef Sofuni A, Iijima H, Moriyasu F, et al. Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. J Gastroenterol. 2005;40:518–525.PubMedCrossRef
10.
Zurück zum Zitat Bali MA, Metens T, Denolin V, De Maertelaer V, Deviere J, Matos C. Pancreatic perfusion: noninvasive quantitative assessment with dynamic contrast-enhanced MR imaging without and with secretin stimulation in healthy volunteers–initial results. Radiology. 2008;247:115–121.PubMedCrossRef Bali MA, Metens T, Denolin V, De Maertelaer V, Deviere J, Matos C. Pancreatic perfusion: noninvasive quantitative assessment with dynamic contrast-enhanced MR imaging without and with secretin stimulation in healthy volunteers–initial results. Radiology. 2008;247:115–121.PubMedCrossRef
11.
Zurück zum Zitat Kubo S, Yamamoto K, Magata Y, et al. Assessment of pancreatic blood flow with positron emission tomography and oxygen-15 water. Ann Nucl Med. 1991;5:133–138.PubMedCrossRef Kubo S, Yamamoto K, Magata Y, et al. Assessment of pancreatic blood flow with positron emission tomography and oxygen-15 water. Ann Nucl Med. 1991;5:133–138.PubMedCrossRef
12.
Zurück zum Zitat Komar G, Kauhanen S, Liukko K, et al. Decreased blood flow with increased metabolic activity: a novel sign of pancreatic tumor aggressiveness. Clin Cancer Res. 2009;15:5511–5517.PubMedCrossRef Komar G, Kauhanen S, Liukko K, et al. Decreased blood flow with increased metabolic activity: a novel sign of pancreatic tumor aggressiveness. Clin Cancer Res. 2009;15:5511–5517.PubMedCrossRef
13.
Zurück zum Zitat Meyer JS, Hayman LA, Yamamoto M, Sakai F, Nakajima S. Local cerebral blood flow measured by CT after stable xenon inhalation. AJR Am J Roentgenol. 1980;135:239–251.PubMed Meyer JS, Hayman LA, Yamamoto M, Sakai F, Nakajima S. Local cerebral blood flow measured by CT after stable xenon inhalation. AJR Am J Roentgenol. 1980;135:239–251.PubMed
14.
Zurück zum Zitat Gur D, Good WF, Wolfson SK Jr, Yonas H, Shabason L. In vivo mapping of local cerebral blood flow by xenon-enhanced computed tomography. Science. 1982;215:1267–1268.PubMedCrossRef Gur D, Good WF, Wolfson SK Jr, Yonas H, Shabason L. In vivo mapping of local cerebral blood flow by xenon-enhanced computed tomography. Science. 1982;215:1267–1268.PubMedCrossRef
15.
Zurück zum Zitat Murakami T, Hori M, Kim T, et al. Xenon-inhalation computed tomography for noninvasive quantitative measurement of tissue blood flow in hepatocellular carcinoma. Invest Radiol. 2004;39:210–215.PubMedCrossRef Murakami T, Hori M, Kim T, et al. Xenon-inhalation computed tomography for noninvasive quantitative measurement of tissue blood flow in hepatocellular carcinoma. Invest Radiol. 2004;39:210–215.PubMedCrossRef
16.
Zurück zum Zitat Sase S, Monden M, Oka H, Dono K, Fukuta T, Shibata I. Hepatic blood flow measurements with arterial and portal blood flow mapping in the human liver by means of xenon CT. J Comput Assist Tomogr. 2002;26:243–249.PubMedCrossRef Sase S, Monden M, Oka H, Dono K, Fukuta T, Shibata I. Hepatic blood flow measurements with arterial and portal blood flow mapping in the human liver by means of xenon CT. J Comput Assist Tomogr. 2002;26:243–249.PubMedCrossRef
17.
Zurück zum Zitat Sase S, Suzuki M, Ikeda H, et al. Quantitative multilevel mapping of hepatic blood flow by xenon computed tomography using aorta. J Comput Assist Tomogr. 2003;27:647–651.PubMedCrossRef Sase S, Suzuki M, Ikeda H, et al. Quantitative multilevel mapping of hepatic blood flow by xenon computed tomography using aorta. J Comput Assist Tomogr. 2003;27:647–651.PubMedCrossRef
18.
Zurück zum Zitat World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2000;284:3043–3045. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2000;284:3043–3045.
19.
Zurück zum Zitat Kalender WA, Polacin A, Eidloth H, Kashiwagi S, Yamashita T, Nakano S. Brain perfusion studies by xenon-enhanced CT using washin/washout study protocols. J Comput Assist Tomogr. 1991;15:816–822.PubMedCrossRef Kalender WA, Polacin A, Eidloth H, Kashiwagi S, Yamashita T, Nakano S. Brain perfusion studies by xenon-enhanced CT using washin/washout study protocols. J Comput Assist Tomogr. 1991;15:816–822.PubMedCrossRef
20.
Zurück zum Zitat Kety SS. The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev. 1951;3:1–41.PubMed Kety SS. The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev. 1951;3:1–41.PubMed
21.
Zurück zum Zitat Sase S. Correction method for end-tidal xenon concentration in CBF measurements with xenon-enhanced CT. J Comput Assist Tomogr. 1996;20:688–692.PubMedCrossRef Sase S. Correction method for end-tidal xenon concentration in CBF measurements with xenon-enhanced CT. J Comput Assist Tomogr. 1996;20:688–692.PubMedCrossRef
22.
Zurück zum Zitat Kuwahara K, Sasaki T, Kuwada Y, Murakami M, Yamasaki S, Chayama K. Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival. Pancreas. 2003;26:344–349.PubMedCrossRef Kuwahara K, Sasaki T, Kuwada Y, Murakami M, Yamasaki S, Chayama K. Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival. Pancreas. 2003;26:344–349.PubMedCrossRef
23.
Zurück zum Zitat Tanigawa N, Amaya H, Matsumura M, et al. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res. 1996;56:2671–2676.PubMed Tanigawa N, Amaya H, Matsumura M, et al. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res. 1996;56:2671–2676.PubMed
25.
Zurück zum Zitat Passe TJ, Bluemke DA, Siegelman SS. Tumor angiogenesis: tutorial on implications for imaging. Radiology. 1997;203:593–600.PubMed Passe TJ, Bluemke DA, Siegelman SS. Tumor angiogenesis: tutorial on implications for imaging. Radiology. 1997;203:593–600.PubMed
26.
Zurück zum Zitat Miles KA. Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review. Eur J Radiol. 1999;30:198–205.PubMedCrossRef Miles KA. Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review. Eur J Radiol. 1999;30:198–205.PubMedCrossRef
27.
Zurück zum Zitat Tateishi U, Nishihara H, Watanabe S, Morikawa T, Abe K, Miyasaka K. Tumor angiogenesis and dynamic CT in lung adenocarcinoma: radiologic-pathologic correlation. J Comput Assist Tomogr. 2001;25:23–27.PubMedCrossRef Tateishi U, Nishihara H, Watanabe S, Morikawa T, Abe K, Miyasaka K. Tumor angiogenesis and dynamic CT in lung adenocarcinoma: radiologic-pathologic correlation. J Comput Assist Tomogr. 2001;25:23–27.PubMedCrossRef
28.
Zurück zum Zitat Dietrich CF, Ignee A, Braden B, Barreiros AP, Ott M, Hocke M. Improved differentiation of pancreatic tumors using contrast-enhanced endoscopic ultrasound. Clin Gastroenterol Hepatol. 2008;6:590–597.PubMedCrossRef Dietrich CF, Ignee A, Braden B, Barreiros AP, Ott M, Hocke M. Improved differentiation of pancreatic tumors using contrast-enhanced endoscopic ultrasound. Clin Gastroenterol Hepatol. 2008;6:590–597.PubMedCrossRef
29.
Zurück zum Zitat Weidner N, Folkman J. Tumoral vascularity as a prognostic factor in cancer. Important Adv Oncol. 1996;167–190. Weidner N, Folkman J. Tumoral vascularity as a prognostic factor in cancer. Important Adv Oncol. 1996;167–190.
30.
Zurück zum Zitat Ikeda N, Adachi M, Taki T, et al. Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer. 1999;79:1553–1563.PubMedCrossRef Ikeda N, Adachi M, Taki T, et al. Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer. 1999;79:1553–1563.PubMedCrossRef
31.
Zurück zum Zitat Linder S, Blasjo M, von Rosen A, Parrado C, Falkmer UG, Falkmer S. Pattern of distribution and prognostic value of angiogenesis in pancreatic duct carcinoma: a semiquantitative immunohistochemical study of 45 patients. Pancreas. 2001;22:240–247.PubMedCrossRef Linder S, Blasjo M, von Rosen A, Parrado C, Falkmer UG, Falkmer S. Pattern of distribution and prognostic value of angiogenesis in pancreatic duct carcinoma: a semiquantitative immunohistochemical study of 45 patients. Pancreas. 2001;22:240–247.PubMedCrossRef
32.
Zurück zum Zitat Niedergethmann M, Hildenbrand R, Wostbrock B, et al. High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas. Pancreas. 2002;25:122–129.PubMedCrossRef Niedergethmann M, Hildenbrand R, Wostbrock B, et al. High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas. Pancreas. 2002;25:122–129.PubMedCrossRef
33.
Zurück zum Zitat D’Onofrio M, Zamboni GA, Malago R, et al. Resectable pancreatic adenocarcinoma: is the enhancement pattern at contrast-enhanced ultrasonography a pre-operative prognostic factor? Ultrasound Med Biol. 2009;35:1929–1937.PubMedCrossRef D’Onofrio M, Zamboni GA, Malago R, et al. Resectable pancreatic adenocarcinoma: is the enhancement pattern at contrast-enhanced ultrasonography a pre-operative prognostic factor? Ultrasound Med Biol. 2009;35:1929–1937.PubMedCrossRef
34.
Zurück zum Zitat Marion-Audibert AM, Barel C, Gouysse G, et al. Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. Gastroenterology. 2003;125:1094–1104.PubMedCrossRef Marion-Audibert AM, Barel C, Gouysse G, et al. Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. Gastroenterology. 2003;125:1094–1104.PubMedCrossRef
35.
Zurück zum Zitat Couvelard A, O’Toole D, Turley H, et al. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. Br J Cancer. 2005;92:94–101.PubMedCrossRef Couvelard A, O’Toole D, Turley H, et al. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. Br J Cancer. 2005;92:94–101.PubMedCrossRef
36.
Zurück zum Zitat Takahashi Y, Akishima-Fukasawa Y, Kobayashi N, et al. Prognostic value of tumor architecture, tumor-associated vascular characteristics, and expression of angiogenic molecules in pancreatic endocrine tumors. Clin Cancer Res. 2007;13:187–196.PubMedCrossRef Takahashi Y, Akishima-Fukasawa Y, Kobayashi N, et al. Prognostic value of tumor architecture, tumor-associated vascular characteristics, and expression of angiogenic molecules in pancreatic endocrine tumors. Clin Cancer Res. 2007;13:187–196.PubMedCrossRef
Metadaten
Titel
Xenon-Inhalation Computed Tomography for Noninvasive Quantitative Measurement of Tissue Blood Flow in Pancreatic Tumor
verfasst von
Masaru Kubota
Takamichi Murakami
Hiroaki Nagano
Hidetoshi Eguchi
Shigeru Marubashi
Shogo Kobayashi
Hiroshi Wada
Masahiro Tanemura
Keizo Dono
Shoji Nakamori
Masato Sakon
Morito Monden
Masaki Mori
Yuichiro Doki
Publikationsdatum
01.03.2012
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 3/2012
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1915-4

Weitere Artikel der Ausgabe 3/2012

Digestive Diseases and Sciences 3/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.